Nisa Investment Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77K | Hold |
148
| – | – | ﹤0.01% | 2542 |
|
|
2025
Q1 | $2.66K | Hold |
148
| – | – | ﹤0.01% | 2393 |
|
|
2024
Q4 | $2.49K | Sell |
148
-10
| -6% | -$168 | ﹤0.01% | 2421 |
|
|
2024
Q3 | $2.56K | Sell |
158
-147
| -48% | -$2.38K | ﹤0.01% | 2350 |
|
|
2024
Q2 | $2.51K | Buy |
305
+262
| +609% | +$2.15K | ﹤0.01% | 2353 |
|
|
2024
Q1 | $639 | Buy |
43
+29
| +207% | +$431 | ﹤0.01% | 2458 |
|
|
2023
Q4 | $196 | Hold |
14
| – | – | ﹤0.01% | 2560 |
|
|
2023
Q3 | $146 | Sell |
14
-2
| -13% | -$21 | ﹤0.01% | 2703 |
|
|
2023
Q2 | $210 | Sell |
16
-640
| -98% | -$8.4K | ﹤0.01% | 2698 |
|
|
2023
Q1 | $9K | Buy |
656
+640
| +4,000% | +$8.78K | ﹤0.01% | 2175 |
|
|
2022
Q4 | $0 | Buy |
+16
| New | – | ﹤0.01% | 2692 |
|
|
2014
Q2 | – | Sell |
-1,460
| Closed | -$57K | – | 1325 |
|
|
2014
Q1 | $57K | Buy |
+1,460
| New | +$57K | ﹤0.01% | 1319 |
|